Subscription price for Promore Pharma’s warrants TO1 determined
STOCKHOLM, January 31, 2019 – The subscription price for warrant TO1 in Promore Pharma AB (publ) has been determined according to the terms and conditions for the warrants to 23.30 SEK per share.The subscription period starts 4 February and continues until 22 February 2019. For additional information, please contact Jonas Ekblom, President and CEO Phone: [+46] 736 777 540 Email: jonas.ekblom@promorepharma.com Jenni Björnulfson, CFO Phone: [+46] 708 55 38 05 Email: jenni.bjornulfson@promorepharma.com Promore Pharma’s Certified Adviser is Redeye. Phone: [+46] 8 121